Get the Stockscreener App
73.90
9.07%
-6.93
Billiontoone Inc stock is traded at $73.90, with a volume of 740.00K.
It is down -9.07% in the last 24 hours and down -13.68% over the past month.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.
See More
Previous Close:
$80.83
Open:
$80.83
24h Volume:
740.00K
Relative Volume:
3.17
Market Cap:
$3.39B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.93%
1M Performance:
-13.68%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$68.14
$86.01
1-Week Range:
$68.14
$86.01
52-Week Range:
$66.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Name
Billiontoone Inc
Sector
Industry
Phone
-
Address
-
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
73.97 | 3.70B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
513.67 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
200.18 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
618.93 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
117.27 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.99 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Dec-01-25 | Initiated | BTIG Research | Buy |
| Dec-01-25 | Initiated | JP Morgan | Overweight |
| Dec-01-25 | Initiated | Jefferies | Hold |
| Dec-01-25 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Initiated | Stifel | Buy |
| Dec-01-25 | Initiated | Wells Fargo | Equal Weight |
| Dec-01-25 | Initiated | William Blair | Outperform |
View All
Billiontoone Inc Stock (BLLN) Latest News
Wells Fargo & Company Has Lowered Expectations for Billiontoone (NASDAQ:BLLN) Stock Price - MarketBeat
BTIG lowers BillionToOne stock price target on valuation multiples - Investing.com
Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat
Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Canada
BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com South Africa
Billiontoone (NASDAQ:BLLN) Announces Earnings Results - MarketBeat
Billiontoone Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: BillionToOne’s Q4 2025 sees robust growth, stock dips - Investing.com India
BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
BillionToOne Raises 2026 Guidance, Aligns Incentive Plan - TipRanks
BillionToOne: Q4 Earnings Snapshot - marketscreener.com
(BLLN) BillionToOne Expects 2026 Revenue Range $430M-$445M, vs. FactSet Est of $405.1M - marketscreener.com
Earnings Flash (BLLN) BillionToOne Posts Q4 EPS $0.11, vs. FactSet Est of $0.06 - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q4 Revenue $96.1M, vs. FactSet Est of $87.2M - marketscreener.com
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - GlobeNewswire
Billiontoone (NASDAQ:BLLN) Trading Down 5.7%Time to Sell? - MarketBeat
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
BillionToOne: Overview of Fourth Quarter Financial Results - Bitget
Billiontoone (NASDAQ:BLLN) Trading Up 6%Time to Buy? - MarketBeat
BillionToOne Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView
BillionToOne (BLLN) Launches Two New Add-ons for Northstar Select - Yahoo Finance
InvestingPro’s Fair Value spotted BillionToOne 46% drop in advance By Investing.com - Investing.com UK
BLLN Should I Buy - Intellectia AI
BLLN PE Ratio & Valuation, Is BLLN Overvalued - Intellectia AI
BillionToOne Stock Slumps 13% in February. Analysts Still See $135 Fair Value - TIKR.com
BillionToOne stock sinks 16% ahead of March earnings: what traders are watching - Bez Kabli
Billiontoone (NASDAQ:BLLN) Reaches New 1-Year LowTime to Sell? - MarketBeat
Five new option listings and three option delistings on February 19th - TipRanks
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
BillionToOne, Inc. Announces Q4 and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
Oguzhan Atay reports 3.2M-share BillionToOne (BLLN) ownership stake - Stock Titan
BillionToOne reaffirms FY25 guidance - MSN
BillionToOne, Inc.Class A common stock (Nasdaq:BLLN) Stock Quote - The Chronicle-Journal
Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test - Mugglehead Investment Magazine
BillionToOne expands liquid biopsy platform with two add-on tests By Investing.com - Investing.com Australia
BillionToOne Expands Northstar Platform with Launch of Two New A - GuruFocus
BillionToOne expands liquid biopsy platform with two add-on tests - Investing.com Nigeria
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - Finviz
BillionToOne, Inc. Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - marketscreener.com
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PR Newswire
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - BioSpace
BillionToOne initiated with a Hold at Jefferies - MSN
Billiontoone Inc Stock (BLLN) Financials Data
There is no financial data for Billiontoone Inc (BLLN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.02%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):